BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 26, 2019
View Archived Issues
Opioids impervious to GLP-1 agonists
Read More
Unexpected role of reduced myelination in Williams syndrome
Read More
Missense mutation in myoglobin causes an adult-onset autosomal dominant myopathy
Read More
STELLAR-3 study of selonsertib does not meet prespecified week 48 primary endpoint
Read More
Janssen initiates phase I study of JNJ-67571244 in patients with AML or MDS
Read More
Allegro Ophthalmics names new anti-integrin product for dry eye disease
Read More
EDP-514 demonstrates potent preclinical antiviral activity
Read More
CYFRA 21-1 as novel prognostic marker in advanced liver disease
Read More
ANGPTL2 knockdown results in mouse model of spontaneous aortic valve stenosis
Read More
Tachykinin NK1 receptor antagonists suppress leukemic cell growth
Read More
Kezar Life Sciences presents new compounds with antitumoral activity
Read More
DOC2A Ca2+ sensor is overexpressed in temporal lobe epilepsy in humans and rat models
Read More
OMPTA agent POL-7306 is potent against Gram-negative bacteria in vitro and in vivo
Read More
GlaxoSmithKline patents new HBV inhibitors
Read More
Takeda presents JAK inhibitors
Read More
hSTING modulators disclosed in GlaxoSmithKline patent
Read More
Takeda identifies glutamate receptor agonists
Read More
Structure, activity described for AMG-510, the first-in-human covalent inhibitor of KRAS G12C
Read More
University of Miami presents new compositions for epidermolysis bullosa
Read More
FDA approves Duobrii for plaque psoriasis
Read More
Pimavanserin begins phase III for major depressive disorder
Read More
ReNeuron reports new data from phase I/IIa study of hRPC therapy candidate for retinitis pigmentosa
Read More
Japanese phase III study of delgocitinib in pediatric atopic dermatitis meets primary endpoint
Read More
Novartis describes activity in vivo of TLR7 agonist LHC-165, now entering phase I
Read More
NIH to send 3-D tissue chips into space to study aging and diseases accelerated in microgravity
Read More